Investing.com -- AbbVie (NYSE: ABBV) saw its shares jump more than 4% in premarket trading Friday after the company's profit ...

AbbVie (NYSE: ABBV) stock rose 4.2% after the drugmaker forecast 2025 profit above estimates, as strong sales of its newer ...

Investing.com -- RBC Capital Markets has initiated coverage on Greencore Group (LON: GNC) with an 'outperform' rating, citing the company's improving profitability, growth initiatives, and potential ...

Going forward, CII shares the outlook articulated by the Survey on India’s growth prospects by projecting a GDP growth rate in the range of 6.3-6.8 per cent for 2025-26 versus 6.4 per cent in the ...

Despite the regulatory setback, BioArctic's partner Eisai has stated that the safety profile of lecanemab reported in clinical practice in the United States, Japan, and other countries is consistent ...

The price jump was a direct consequence of Upbit, South Korea's leading cryptocurrency exchange, deciding to list VIRTUAL in three different markets: VIRTUAL/KRW, VIRTUAL/USDT, and VIRTUAL/BTC. This ...